Provexis Share News (PXS)
PXS Share
PXS Share
PXS Share
PXS Share
PXS
PXS Share
PXS Level 2
PXS Live
PXS Broker
PXS Directors
PXS Financial
PXS
PXS Short
PXS
Last checked at -
First-half numbers from specialist engineer GKN beat market expectations, with pre-tax profits leaping 43 per cent. Nigel Stein, chief executive, also gave some upbeat interviews, indicating that, while many of GKN's customers were cautious about the rest of 2012, "no one is pressing alarm buttons"
Read moreAir Partner, a provider of air charter services, has said underlying profit before tax for the year is expected to meet its forecasts. The firm's cost reduction programme is also now nearly complete and will realise 'significant cost savings' in the next financial year, with a one off restructuring
Read moreSports nutrition specialist Provexis said an industrial scale production of Fruitflow powder, was successfully completed in 2012. Fruitflow is Provexis's tomato extract which inhibits platelet aggregating and therefore reduces the chance of heart disease. Provexis has identified a potential applic
Read moreLife insurance stocks were on the rise on Thursday afternoon, helped by FTSE 100 savings, investment and insurance group Old Mutual. Shares in Old Mutual roared higher on Thursday after announcing that it is to sell its Nordic business Skandia AB for £2.1bn in an effort to "reduce complexity" and p
Read moreMedical food and dietary supplement developer Provexis disappointed investors with widened losses for the six months ended 30 September. The share price fell 23.08% to 1.75p by 13:05. The losses, which grew from £1m to £1.5m, came despite revenues doubling from £0.7m to £1.5m after costs rose signi
Read moreMedical food and dietary supplement developer Provexis reported a wider pre-tax loss, hurt by increased research and development expenses, while its plans to acquire a sports nutrition products manufacturer failed to inspire investors. For the year ended March 31, Provexis posted a loss before tax
Read moreMedical food and dietary supplement developer Provexis said pre-tax losses almost doubled as it increased research and development spending. Investment in R&D increased to £612,171 in the period, up from £289,125 in the same period last year, as the group broadens its product pipeline. The group
Read moreThe board of functional and medical food company Provexis has set itself the task in the coming year of maximising the commercial opportunity for Fruitflow, its patented tomato extract which aims to improve heart health. The marketing strategy for Fruitflow is now being finalised and the technology
Read moreFunctional foods developer Provexis has gained approval from the European Food Safety Authority (EFSA) to use its Fruitflow technology in dietary supplements. Fruitflow was already allowed to be used in drinks by the EFSA. Provexis can also use the claim that Fruitflow "helps maintain normal plate
Read moreLONDON (Dow Jones)--Provexis PLC (PXS.LN), a company which focuses on the discovery, development and licensing of scientifically-proven functional food, medical food and dietary supplement technologies, Monday announces a widening of the European Food Safety Authority (EFSA) opinion on the Company's
Read moreLONDON (Dow Jones)--Provexis PLC (PXS.LN), which focuses on the discovery, development and licensing of scientifically-proven functional food, medical food and dietary supplement technologies, said Tuesday it has raised net proceeds of GBP88,869 by drawing down on its Equity Financing Facility with
Read moreThe movements of the blue-chip index looked like they were being directed by the grand old Duke of York on Wednesday, with the market finishing neither up nor down. British Sky Broadcasting (BSkyB) was predictably outraged at the decision by telecoms regulator Ofcom to order it to make its two top
Read moreFunctional foods developer Provexis expects to have net cash of £7m at the end of March 2010. It has also entered into a three-year, £25m equity financing facility provided by Evolution Securities through its subsidiary Darwin Strategic. This could be used to help finance acquisitions. Renew Holdi
Read moreShares in medical food and dietary supplement developer Provexis shot up on Tuesday after it published the results of a trial of its Fruitflow product, which is designed to reduce the risk of heart attack, stroke and venous thrombosis. Fruitflow, a tomato extract which counters unwanted clot forma
Read moreE-learning company ILX has won three contracts that are expected to produce revenues of more than £0.27m over the life of the contracts. The first contract is to provide project management training to a major government department over a period of three years. The other two contracts are for overse
Read more
Last checked at